欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DK/H/1059/009
药品名称Quetiapin "KRKA"
活性成分
    • Quetiapine 50.0 mg
剂型Prolonged-release tablet
上市许可持有人Krka Sverige AB Göta Ark 175, Medborgarplatsen 25 118 72 Stockholm Sweden
参考成员国 - 产品名称Denmark (DK)
Quetiapin Krka
互认成员国 - 产品名称
    • Iceland (IS)
    • Germany (DE)
      Quentiax retard 50 mg Retardtabletten
    • Belgium (BE)
      Quetiapine Krka 50 mg tabletten met verlengde afgifte
    • Ireland (IE)
    • Austria (AT)
      Quetiapin Krka 50 mg Retardtabletten
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
      QUENTIAX® SR
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
      Kventiax SR
    • Latvia (LV)
      Kventiax 50 mg ilgstošās darbības tabletes
    • Lithuania (LT)
      Kventiax 50 mg pailginto atpalaidavimo tabletės
    • Estonia (EE)
      KVENTIAX SR
    • Bulgaria (BG)
      Kventiax SR
    • Czechia (CZ)
      Kventiax Prolong 50 mg
    • Romania (RO)
      Kventiax EP 50 mg comprimate cu eliberare prelungită
    • Slovakia (SK)
      Kventiax SR 50 mg tablety s predĺženým uvoľňovaním
    • Slovenia (SI)
      Kventiax SR 50mg filmsko obložene tablete s podaljšanim sproščanjem
许可日期2015/10/15
最近更新日期2024/10/04
药物ATC编码
    • N05AH04 quetiapine
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase